...
首页> 外文期刊>Human Immunology: Official Journal of the American Society for Histocompatibility and Immunogenetics >Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients
【24h】

Human leukocyte antigen class I alleles and haplotypes associated with primary hepatocellular carcinoma in persistent HBV-infected patients

机译:持续性HBV感染患者中与原发性肝细胞癌相关的人类白细胞抗原I类等位基因和单倍型

获取原文
获取原文并翻译 | 示例

摘要

Many studies have shown that Human leukocyte antigen (HLA) class I alleles are associated with the development of various cancers. However, its role in hepatocellular carcinoma (HCC) is still unknown. To investigate whether HLA class I allelic polymorphism is related to the development of hepatitis B virus(HBV)-associated HCC, a total of 326 HBV-infected patients (138 individuals with HCC and 188 well-matched controls without HCC) were enrolled in this study. HLA-A, -B, and -C were genotyped by polymerase chain reaction-sequencing based typing (PCR-SBT) method. We identified HLA-B*35:01:01G as a risk factor for HBV-related HCC development independent of our previous findings in HLA region (OR, 12.04; p, 0.0028; pc, 0.04). HLA-A*11:01:01G, B*58:01:01G, C*03:02:01G and some of their extended haplotypes were found as potential susceptible factors for HCC development. HLA-B*46:01:01G and some of its extended haplotypes were found as potential protective factors for HCC development. Our results support that specific HLA class I alleles and haplotypes may affect the risk of HBV-related HCC development. The findings may help to determine better approaches for prevention and treatment of HCC in these patients.
机译:许多研究表明,人类白细胞抗原(HLA)I类等位基因与各种癌症的发生有关。但是,其在肝细胞癌(HCC)中的作用仍是未知的。为了调查HLA I类等位基因多态性是否与乙型肝炎病毒(HBV)相关的HCC的发生有关,共招募了326例HBV感染患者(138例HCC患者和188例完全匹配的无HCC对照)。研究。通过基于聚合酶链反应测序的分型(PCR-SBT)方法对HLA-A,-B和-C进行基因分型。我们将HLA-B * 35:01:01G确定为HBV相关HCC发生的危险因素,而与我们先前在HLA地区的发现无关(OR,12.04; p,0.0028; pc,0.04)。发现HLA-A * 11:01:01G,B * 58:01:01G,C * 03:02:01G及其某些扩展单倍型是HCC发生的潜在易感因素。发现HLA-B * 46:01:01G及其一些扩展单倍型是HCC发生的潜在保护因子。我们的结果支持特定的HLA I类等位基因和单倍型可能影响HBV相关HCC发生的风险。这些发现可能有助于确定预防和治疗这些患者的更好方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号